Globeflex Capital L P Supernus Pharmaceuticals, Inc. Transaction History

Globeflex Capital L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $617,346 - $803,956	-25,563 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$17.7 - $25.81 $1,132 - $1,651	64 Added 0.25%	25,563 $643,000
Q2 2020 Aug 12, 2020	BUY	$17.09 - $24.89 $76,426 - $111,308	4,472 Added 21.27%	25,499 $606,000
Q4 2019 Feb 07, 2020	SELL	$19.93 - $29.13 $16,183 - $23,653	-812 Reduced 3.72%	21,027 $499,000
Q3 2019 Nov 13, 2019	SELL	$25.47 - $33.37 $119,709 - $156,839	-4,700 Reduced 17.71%	21,839 $600,000
Q2 2019 Aug 12, 2019	SELL	$29.96 - $38.87 $659 - $855	-22 Reduced 0.08%	26,539 $878,000
Q1 2019 May 10, 2019	SELL	$32.77 - $41.99 $21,562 - $27,629	-658 Reduced 2.42%	26,561 $931,000
Q4 2018 Feb 14, 2019	SELL	$30.84 - $49.51 $238,763 - $383,306	-7,742 Reduced 22.14%	27,219 $904,000
Q3 2018 Nov 09, 2018	SELL	$42.7 - $56.55 $17,080 - $22,620	-400 Reduced 1.13%	34,961 $1.76 Million
Q2 2018 Aug 10, 2018	SELL	$44.1 - $59.85 $123,480 - $167,580	-2,800 Reduced 7.34%	35,361 $2.12 Million
Q1 2018 May 14, 2018	BUY	$37.15 - $46.9 $709,565 - $895,790	19,100 Added 100.2%	38,161 $1.75 Million
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $700,491 - $946,378	19,061	19,061 $762,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.96B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.